Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from NanoVibronix ( (NAOV) ) is now available.
On June 4, 2025, NanoVibronix announced the appointment of Doron Besser as its new CEO following the retirement of Brian Murphy, who will remain on the board. This leadership transition coincides with the company’s strategic acquisition of ENvue, enhancing its growth potential and market positioning in the medical device sector.
More about NanoVibronix
NanoVibronix, Inc. is a medical technology company specializing in non-invasive and minimally invasive solutions for clinical and home care settings. The company focuses on acoustic-based therapeutic technologies, such as PainShield® and UroShield®, and the ENvue™ Navigation Platform, which assists in the placement of feeding tubes. Headquartered in Tyler, Texas, with R&D in Israel, NanoVibronix aims to advance standards in non-invasive therapy and navigation, emphasizing patient safety and technology innovation.
Average Trading Volume: 4,222,179
Technical Sentiment Signal: Sell
Current Market Cap: $2.92M
Find detailed analytics on NAOV stock on TipRanks’ Stock Analysis page.